Cynata Therapeutics Is An Australian Biotechnology Company Based In Melbournespecializing In Regenerative Medicine And Stem Cell Therapiesfounded In 2003The Company Focuses On Developing Scalable Cell Therapies Through Its Proprietary Cymerusa C Platformwhich Utilizes Induced Pluripotent Stem Cellsipscsto Produce Mesenchymal Stem Cellsmscsat A Commercial Scale The Cymerusa C Platform Addresses Challenges In Msc Manufacturingensuring Consistent Quality And Scalabilitykey Products Include Cyp 001A Therapy For Acute Steroid Resistant Graft Versus Host Diseasewhich Has Completed A Phase I Trial And Is Moving Into Phase Iithe Company Is Also Conducting A Phase Iii Clinical Trial For Osteoarthritis Therapy And Has Ongoing Trials For Diabetic Foot Ulcerscynata Collaborates With Industry Leadersincluding A Strategic Partnership With Fujifilmto Enhance Manufacturing Processes And Accelerate Development
United States
